Patients with refractory months autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy20

Hematopoietic Stem Cells Bone Marrow Cells, Cultured Bone Marrow Cells Stem Cells T-Lymphocytes Antilymphocyte Serum Transplants T-Lymphocytes, Cytotoxic Liver Lymphocytes Dendritic Cells Portal Vein CD4-Positive T-Lymphocytes Killer Cells, Natural Fetal Blood Mesenchymal Stromal Cells Kidney Clone Cells B-Lymphocytes

Organisms7

Transplantation Chimera Lentivirus Rabbits Mice, Inbred C57BL Rats, Inbred Lew Mice, SCID Mice, Inbred BALB C

Diseases44

Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hodgkin Disease Hematologic Neoplasms Lymphoma Neoplasm, Residual Myelodysplastic Syndromes Leukemia, Myeloid, Acute Leukemia Anemia, Refractory Postoperative Complications Neoplasm Recurrence, Local Liver Failure Anemia, Refractory, with Excess of Blasts Disease Progression Cadaver Acute Disease Liver Diseases Anemia, Aplastic Kidney Failure, Chronic Precursor Cell Lymphoblastic Leukemia-Lymphoma Cytomegalovirus Infections Leukemia, Myeloid Disease Models, Animal Bronchiolitis Obliterans Hematologic Diseases Neoplasms Infection Blood Group Incompatibility Chronic Disease End Stage Liver Disease Liver Cirrhosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hepatic Veno-Occlusive Disease Lymphoproliferative Disorders Brain Death Liver Failure, Acute Liver Neoplasms Primary Graft Dysfunction Thrombocytopenia Delayed Graft Function Opportunistic Infections

Chemicals and Drugs42

Melphalan Antigens, CD34 Carmustine Cyclophosphamide Granulocyte Colony-Stimulating Factor Etoposide Busulfan Cytarabine Immunosuppressive Agents Thalidomide Myeloablative Agonists Kanamycin Kinase Vincristine Idarubicin Antibodies, Monoclonal, Murine-Derived Prednisone Dexamethasone Antineoplastic Agents, Alkylating Antineoplastic Agents Antibodies, Monoclonal Doxorubicin Antigens, CD Cyclosporine Tacrolimus Recombinant Proteins HLA Antigens Antilymphocyte Serum Vidarabine Thiotepa Mycophenolic Acid Boronic Acids Pyrazines Antigens, Neoplasm Antibodies, Neoplasm ABO Blood-Group System Azathioprine Isoantibodies Methylprednisolone Interleukin-2 Ifosfamide Isoantigens Mitoxantrone

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Kidney Transplantation Treatment Outcome Hematopoietic Stem Cell Mobilization Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Salvage Therapy Cell Transplantation Heart Transplantation Bone Marrow Purging Lung Transplantation Antineoplastic Combined Chemotherapy Protocols Remission Induction Leukapheresis Whole-Body Irradiation Disease-Free Survival Retrospective Studies Survival Analysis Organ Transplantation Survival Rate Blood Transfusion, Autologous Follow-Up Studies Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Prognosis Feasibility Studies Blood Component Removal Transplantation, Isogeneic Genetic Therapy Cord Blood Stem Cell Transplantation Cell Separation Transplantation, Heterotopic Heart-Lung Transplantation Prospective Studies Blood Cell Count Colony-Forming Units Assay Immunomagnetic Separation Immunosuppression Cell Culture Techniques Transduction, Genetic Histocompatibility Testing Flow Cytometry Skin Transplantation Mesenchymal Stem Cell Transplantation Fetal Tissue Transplantation Transplantation, Heterologous Tissue Transplantation Multivariate Analysis Corneal Transplantation Polymerase Chain Reaction Brain Tissue Transplantation Facial Transplantation Organ Preservation Donor Selection Risk Factors Drug Administration Schedule Lymphocyte Culture Test, Mixed Tissue and Organ Harvesting Lymphocyte Activation Actuarial Analysis Treatment Failure Postoperative Period Disease Models, Animal Fatal Outcome Lymphocyte Transfusion Patient Selection Lymphocyte Depletion Neoplasm Transplantation Hand Transplantation Immunotherapy Biopsy Kaplan-Meier Estimate Immunotherapy, Adoptive Drug Therapy, Combination Blood Transfusion Platelet Count Models, Animal Infusions, Intravenous Bone Transplantation Immunophenotyping Platelet Transfusion Anastomosis, Surgical Pilot Projects Severity of Illness Index Leukocyte Count Incidence Reoperation Cohort Studies Postoperative Care Drug Evaluation Immunohistochemistry Cryopreservation

Phenomena and Processes25

Graft Survival Time Factors Graft Rejection Transplantation Immunology Graft vs Tumor Effect Hematopoiesis Refractory Period, Electrophysiological Blood Cell Count Genetic Vectors Transduction, Genetic Transplantation Tolerance Cell Differentiation Histocompatibility Lymphocyte Activation Cytotoxicity, Immunologic Dose-Response Relationship, Drug Platelet Count Immune Tolerance Graft vs Leukemia Effect Chimerism Leukocyte Count Regeneration Drug Resistance, Neoplasm Cell Survival Cell Proliferation

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups2

Tissue Donors Living Donors

Health Care24

Treatment Outcome Disease-Free Survival Retrospective Studies Survival Analysis Survival Rate Follow-Up Studies Feasibility Studies Prospective Studies Tissue and Organ Procurement Multivariate Analysis Waiting Lists Donor Selection Risk Factors Actuarial Analysis Treatment Failure Postoperative Period Fatal Outcome Patient Selection Kaplan-Meier Estimate Pilot Projects Severity of Illness Index Incidence Cohort Studies Postoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Multiple Myeloma Kidney Transplantation Melphalan Treatment Outcome Hematopoietic Stem Cell Mobilization Graft Survival Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Salvage Therapy Lymphoma, Non-Hodgkin Cell Transplantation Recurrence Heart Transplantation Antigens, CD34 Bone Marrow Purging Lung Transplantation Carmustine Antineoplastic Combined Chemotherapy Protocols Remission Induction Cyclophosphamide Graft vs Host Disease Leukapheresis Granulocyte Colony-Stimulating Factor Whole-Body Irradiation Hematopoietic Stem Cells Disease-Free Survival Etoposide Retrospective Studies Survival Analysis Hodgkin Disease Organ Transplantation Busulfan Cytarabine Immunosuppressive Agents Hematologic Neoplasms Survival Rate Blood Transfusion, Autologous Time Factors Graft Rejection Follow-Up Studies Pancreas Transplantation Thalidomide Islets of Langerhans Transplantation Tissue Donors Transplantation Immunology Transplantation Graft vs Tumor Effect Myeloablative Agonists Bone Marrow Transplantation Chimera Kanamycin Kinase Vincristine Prognosis Feasibility Studies Blood Component Removal Transplantation, Isogeneic Lymphoma Idarubicin Neoplasm, Residual Myelodysplastic Syndromes Antibodies, Monoclonal, Murine-Derived Cells, Cultured Prednisone Leukemia, Myeloid, Acute Dexamethasone Leukemia Hematopoiesis Anemia, Refractory Genetic Therapy Antineoplastic Agents, Alkylating Living Donors Cord Blood Stem Cell Transplantation Cell Separation Antineoplastic Agents Transplantation, Heterotopic Bone Marrow Cells Antibodies, Monoclonal Heart-Lung Transplantation Refractory Period, Electrophysiological Prospective Studies Stem Cells Blood Cell Count Colony-Forming Units Assay Immunomagnetic Separation Doxorubicin Immunosuppression Cell Culture Techniques Genetic Vectors Transduction, Genetic Histocompatibility Testing Transplantation Tolerance Tissue and Organ Procurement Lentivirus

No FAQ available that match "patients with refractory months autologous transplantation"